Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
In a podcast from the Immune Deficiency Foundation, “The Big Sick” co-writer, Emily V. Gordon, shared her experiences navigat…
A podcast for physicians, moderated by CSL Behring’s Bill Maltas, discussed the recommendations for diagnosing and treating t…
The World of Promise podcast features a conversation with Dr. Stanford, founder of the Black Doctors COVID-19 Consortium and …
On the latest episode of The New Horizon Talks, experts discuss advancing patient access to specialized care and the European…
In honor of Rare Disease Day later this month, new podcast episode welcomes a special guest to discuss the importance of ment…
CSL’s Ellyn Getz, Director of R&D Patient Partnerships, visits the Advarra podcast to talk about how clinical research studie…
In episode 5, hear from Yann Le Cam, leader of Europe’s rare disease community, EURORDIS. In episode 6, experts explore the p…
New podcast episode explores connection to fly fishing organization that helps disabled veterans and wounded, injured and ill…
Sickle cell disease patients live with a disruptive, painful, life-limiting condition. Hear from two advocates who are workin…
In honor of World Hemophilia Day, podcast discusses access to therapies for those living with hemophilia.
You’re on a first date. Should you or shouldn’t you tell them about your serious medical condition? We have advice from two r…
We discuss ethical questions with expert Hervé Chneiweiss, who serves on the World Health Organization (WHO) committee that’s…
Americas
Asia Pacific
Middle East
Europe
